Skip to main content

Increasing Seaborne Trade Across The Globe To Propel Port Equipment Market

The factors that are expected to fuel the growth of the port equipment market are the increasing seaborne trade across the globe and the growing number of container shipments in Asia Pacific and the Middle East. Various countries have been focusing on developing new ports owing to the increase in vessel count and trade volume. According to the International Chamber of Shipping, 90% of the world’s trade is carried out through seaways as they are ideal for heavy and bulk goods, have large carrying capabilities, and offer competitive freight costs. The global port equipment market size is expected to grow from USD 29.2 billion in 2018 to USD 36.6 million by 2023, at a CAGR of 3.30% during the forecast period. The major driving factors for the port equipment market are the increasing seaborne trade across the globe and the growing number of container shipments in Asia Pacific and the Middle East. Based on equipment type, the straddle carriers segment is estimated to lead the port equipm
Post a Comment

Global Parkinson’s Disease Treatment Market Is Projected To Reach $5.69 Billion by 2022

The global Parkinson’s disease treatment market size is projected to reach USD 5.69 billion by 2022 from an estimated USD 4.24 billion in 2017, at a CAGR of 6.1%. The major factors driving the growth of this market are Growth in the aging population and the associated increase in the prevalence of Parkinson’s disease and growing government funding and support for research



Browse 66 Market Data Tables and 33 Figures spread through 113 Pages and in-depth TOC on "Parkinsons Disease Treatment Market - Global Forecast to 2022"


Globally, the Parkinson’s disease treatment market is witnessing a moderate growth due to factors such as increasing prevalence of Parkinson’s disease; rising geriatric population; and support for research on Parkinson’s disease. 
Over the last few decades, key players operating in this market are focusing on offering new and innovative products. Based on drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period. This is due to carbidopa/levodopa drugs are more potent and widely used in the treatment of Parkinson’s disease in comparison to other therapeutic drugs.


By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register the highest growth rate during the forecast period. Advancements such as 24/7 availability, home delivery, and discount on medicines are driving factors for online pharmacies segment.

On the basis of patient care setting, the market is categorized into hospitals and clinics. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the availability of diagnostics laboratories in the hospital and the presence skilled neurologists.

The Parkinson’s disease treatment market is classified based on regions into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Presence key market players and rising aging population are the major factors driving the Parkinson’s disease treatment market in this region.
Asia to offer lucrative growth opportunities
By region, the global Parkinsons disease treatment market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While Europe is expected to hold the largest share of the market in 2017, Asia is expected to grow at the highest CAGR during the forecast period. Increasing number of players in the region and the rising aging population are some major factors driving the high growth of this regional segment.
Some of the major players operating in the Parkinsons disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany),  Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).
Market Dynamics
Drivers
  • Growth in ageing population and the associated increase in the prevalence of parkinson’s disease
  • Government funding for research
Restraint
  • Availability of alternative treatments
Opportunities
  • Patent expiry of branded drugs
  • Strong pipeline
Request For Specific Customization of the report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=47265247

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Molecular Diagnostics Market Is Prospective To Reach $15.94 Billion By 2027 | CAGR Of 8.4%

The global  molecular diagnostics market  size is projected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at CAGR of 8.4%.  Growth in this market is driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. The molecular diagnostics market is segmented on the basis of product and service, application, technology, end user, and region. Based on product and service, the market is broadly segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to register the highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncol
Post a Comment
Read more

Flavors And Fragrances Market is Expected to Reach USD 24.13 Billion By 2022

The  flavors and fragrances market  is expected to grow from an estimated  USD 21.15 billion in 2017 to USD 24.13 billion by 2022, at a CAGR of 2.67% between 2017 and 2022.  The growing demand for flavors & fragrances from end-use industries such as food & beverage and consumer goods is expected to drive the flavors & fragrances market. The flavors & fragrances market is also expected to grow due to rising demand for consumer products and changing consumer preferences for convenience food products. The market has been segmented on the basis of ingredients, end use, and region. Based on ingredients, the natural ingredients segment is projected to grow at the highest CAGR between 2017 and 2022. This growth of the natural ingredients segment is attributed to the strict regulations related to the use of synthetic flavors & fragrances and growing awareness among populations concerning health and wellness. Download PDF Brochure:  https://www.marketsandmarkets.co
Post a Comment
Read more

Air Traffic Control Market Growth Driving Factors and Research Report, 2025

Increasing demand for scalable air traffic navigation services is fueling the remote tower market. The remote tower system is a remote air traffic control (ATC) room with video-sensor-based surveillance instead of the conventional out-of-the-window view from a real tower. Factors such as modernization of air traffic management (ATM) infrastructure, an increase in the number of airports in emerging economies, and the need for efficient airspace management are anticipated to drive the growth of the air traffic control market. The  global air traffic control market size  is projected to grow from USD 9.3 billion in 2019 to USD 12.3 billion by 2025, at a CAGR of 4.8%. Factors such as modernization of air traffic management (ATM) infrastructure, an increase in the number of airports in emerging economies, and the need for efficient airspace management are anticipated to drive the growth of the air traffic control market. Remote tower systems are gaining popularity as they are cost-effective
Post a Comment
Read more